Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pin Yi

Showing results (131-140 of 174) with videos related to

Pageof 18
Sort By:
Iscience|July 27, 2023
QHRD106 ameliorates ischemic stroke injury as a long-acting tissue kallikrein preparationSi-Yi Xu, Jun-Qiu Jia, Min Sun, et al.
Blood|August 30, 2008
The biologic properties of leukemias arising from BCR/ABL-mediated transformation vary as a function of developmental origin and activity of the p19ARF genePin-Yi Wang, Fay Young, Chun-Yu Chen, et al.
Annals of Biomedical Engineering|January 9, 2026
Design Rules for Robust Coronary Artery Segmentation: A Systematic Analysis of Dataset Size, Windowing, Architectures, and Vessel GeometryMing-Hui Hung, Yu-Wei Chiang, Hao-Yun Liu, et al.
Cancer Genomics & Proteomics|October 28, 2025
Angiogenic Edge of ANGPT2: Genetic Variants Shape Prostate Cancer Prognosis on Androgen Deprivation TherapyYei-Tsung Chen, Pin-Yi Chen, Chi-Fen Chang, et al.
Frontiers in Oncology|June 3, 2021
Rac1, A Potential Target for Tumor TherapyJiaxin Liang, Linda Oyang, Shan Rao, et al.
Bioorganic Chemistry|September 30, 2018
Unusual cadinane-type sesquiterpene glycosides with α-glucosidase inhibitory activities from the fruit of Cornus officinalis Sieb. et ZuucJun He, Jie-Kun Xu, Xue-Ge Pan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2003
Antitumor and antimetastatic activity of IL-23Chia-Hui Lo, Shan-Chih Lee, Pin-Yi Wu, et al.
Biochemical Pharmacology|April 12, 2011
UBE2M-mediated p27(Kip1) degradation in gemcitabine cytotoxicityA-Mei Huang, Yu-Ting Kao, Shinzao Toh, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 18, 2020
Exosomal miRNAs in tumor microenvironmentShiming Tan, Longzheng Xia, Pin Yi, et al.
Molecular Therapy Oncolytics|December 4, 2018
Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune MicroenvironmentNicholas L Denton, Chun-Yu Chen, Brian Hutzen, et al.
Pageof 18

Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
Iscience|July 27, 2023
QHRD106 ameliorates ischemic stroke injury as a long-acting tissue kallikrein preparationSi-Yi Xu, Jun-Qiu Jia, Min Sun, et al.
Blood|August 30, 2008
The biologic properties of leukemias arising from BCR/ABL-mediated transformation vary as a function of developmental origin and activity of the p19ARF genePin-Yi Wang, Fay Young, Chun-Yu Chen, et al.
Annals of Biomedical Engineering|January 9, 2026
Design Rules for Robust Coronary Artery Segmentation: A Systematic Analysis of Dataset Size, Windowing, Architectures, and Vessel GeometryMing-Hui Hung, Yu-Wei Chiang, Hao-Yun Liu, et al.
Cancer Genomics & Proteomics|October 28, 2025
Angiogenic Edge of ANGPT2: Genetic Variants Shape Prostate Cancer Prognosis on Androgen Deprivation TherapyYei-Tsung Chen, Pin-Yi Chen, Chi-Fen Chang, et al.
Frontiers in Oncology|June 3, 2021
Rac1, A Potential Target for Tumor TherapyJiaxin Liang, Linda Oyang, Shan Rao, et al.
Bioorganic Chemistry|September 30, 2018
Unusual cadinane-type sesquiterpene glycosides with α-glucosidase inhibitory activities from the fruit of Cornus officinalis Sieb. et ZuucJun He, Jie-Kun Xu, Xue-Ge Pan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2003
Antitumor and antimetastatic activity of IL-23Chia-Hui Lo, Shan-Chih Lee, Pin-Yi Wu, et al.
Biochemical Pharmacology|April 12, 2011
UBE2M-mediated p27(Kip1) degradation in gemcitabine cytotoxicityA-Mei Huang, Yu-Ting Kao, Shinzao Toh, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 18, 2020
Exosomal miRNAs in tumor microenvironmentShiming Tan, Longzheng Xia, Pin Yi, et al.
Molecular Therapy Oncolytics|December 4, 2018
Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune MicroenvironmentNicholas L Denton, Chun-Yu Chen, Brian Hutzen, et al.
Pageof 18